Key facts
- This page summarizes Andrew J. Murphy's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Dec 2025, 16:17.
Andrew J. Murphy - 05 Dec 2025 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)
- Reporting relationship
- EVP Research
- Issuer ticker
- REGN
- Reported as of
- 05 Dec 2025
- Net transaction value
- -$1,211,285
- SEC form
- 4
- Accepted by SEC
- 09 Dec 2025, 16:17:05 UTC
- Prior SEC filing
- 31 Oct 2025
- Next SEC filing
- 11 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Murphy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew J. Murphy filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 09 Dec 2025.
Change
- Previous filing in this sequence was filed on 31 Oct 2025.
- Current net transaction value: -$1,211,285.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001796226
Primary reporting owner
MURPHY ANDREW J
- Relationship
- EVP Research
- Address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN
- Signature
- /s/ Andrew Murphy
- Signature date
- 09 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
REGN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,715
- Change %
- +7.4%
- Price
- $0.000000
- Shares after
- 53,761
- Date
- 05 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
REGN
transaction
Common Stock
Tax liability
- Transaction value
- $1,211,285
- Shares
- -1,699
- Change %
- -3.2%
- Price
- $712.94
- Shares after
- 52,062
- Date
- 08 Dec 2025
- Ownership
- Direct
REGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,375
- Date
- 05 Dec 2025
- Ownership
- By 401(k) Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
REGN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +18,315
- Change %
- Price
- $0.000000
- Shares after
- 18,315
- Date
- 05 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,315
- Exercise price
- $726.71
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029.
Footnote F2
The stock option award vests in four equal annual installments, commencing one year after the date of grant.